DIA Europe 2019 has ended
Back To Schedule
Tuesday, February 5 • 11:00 - 12:30
#DMD6: Real World Data: How to Deliver its Potential to Support Innovation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

Real World Data (RWD) has the potential to support getting products to patients with unmet needs. It is already supporting key decisions by regulators, HTA bodies, payers and industry but the opportunity for even better use of RWD is huge. This session draws on the expertise of some of the most experienced global experts and through TED-style talks and debate will look at how this opportunity can be realised in Europe.


Daniel Morales, MD, PhD, MRCP


How Industry is Delivering Innovation through Real World Data
Ryan Dean Kilpatrick, PhD

Confidence in Real World Data
Sebastian Schneeweiss, DrSc, MD, MS, FISPE

How a Common Data Model Can Support Innovation
Peter Rijnbeek, PhD

Collaboration between Data Owners to Deliver Quality Data and Robust Analysis
Miriam Sturkenboom, PhD, MPharm, MSc, FISPE


Ryan Kilpatrick

Global Head, Epidemiology, AbbVie
Ryan Kilpatrick is the head of epidemiology at AbbVie, Inc. Prior to this, he held roles in Amgen, GSK and Baxalta. His primary interest is in use of pharmacoepidemiology in drug safety and to support drug development across the product lifecycle.
avatar for Daniel Morales

Daniel Morales

Member PRAC, Pharmacovigilance and Epidemiology Department, University of Dundee
Daniel Morales is a General Practitioner and Epidemiologist at the University of Dundee and current member of the EMA Pharmacovigilance Risk Assessment Committee. His research interests include the use of real world data to support medicines regulation and safer prescribing, and has... Read More →
avatar for Peter Rijnbeek

Peter Rijnbeek

Assistant Professor Medical Informatics, Erasmus Medical Center
Peter Rijnbeek is Assistant Professor at the Erasmus University Medical Center in Rotterdam where he is leading the Health Data Science group at the Department of Medical Informatics (www.healthdatascience.nl). He is co-leading the European Health Data and Evidence Network (EHDEN... Read More →
avatar for Sebastian Schneeweiss

Sebastian Schneeweiss

Professor, Medicine and Epidemiology; Chief of the Div of Pharmacoepidemiology, Harvard Medical School and Brigham and Women's Hospital, United States
Dr. Schneeweiss's research focuses on assessing the effectiveness and safety of biopharmaceuticals in clinical practice. He has developed analytic methods to improve the accuracy of estimating causal treatment effects of new drugs using complex digital healthcare databases. His work... Read More →
avatar for Miriam Sturkenboom

Miriam Sturkenboom

Professor, Julius Global Health, University Medical Center Utrecht
Miriam Sturkenboom is a professor in Observational Data Analysis, a pharmacoepidemiologist, currently working at the Julius Global Health group of University Medical Center Utrecht in the Netherlands. She is a past president of ISPE. Her research focuses on knowledge discovery from... Read More →

Tuesday February 5, 2019 11:00 - 12:30 CET
E1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  DIAmond Sessions, Session
  • Featured Topics Clinical Development ,Pharmacovigilance,Data and Data Standards
  • Tags Session